1. What Is Retrieval-Augmented Generation?
RAG is a way to leverage already-trained large language models such as GPT-4, Gemini, Bard and Llama when building applications powered by artificial intelligence. By adding local knowledge (such as…
Te Whatu Ora Health New Zealand has embarked on a new digital project consolidating patient health information access nationwide for clinicians.WHAT IT’S ABOUT
The Shared Digital Health Records (SDHR) project initially aims to “connect data…
What You Should Know:
– Nimblemind.ai, an innovative AI-powered data infrastructure platform secures $2.5M in funding led by Bread & Butter Ventures, with participation from prominent investors including Great Oaks Venture Capital, SpringTime Ventures, Stone…
Continue Reading
What You Should Know:
– The American Cancer Society (ACS) and Layer Health, an innovator in AI-driven healthcare technology, have announced a multi-year collaboration aimed at accelerating cancer research. This partnership will leverage large language…
Continue Reading
The American Cancer Society (ACS) and healthcare AI company Layer Health announced a multi-year collaboration aimed at using large language models (LLMs) to expedite cancer research.ACS will use Layer Health’s LLM-powered data abstraction platform…
Continue Reading
This year’s HIMSS conference in Las Vegas, which wrapped on Thursday, allowed healthcare technology leaders from around the world to convene and share ideas. As always, the event came with a slew of news…
Continue Reading
Artificial intelligence is the technology that dominates the conversation, and 2025 will be the “year of adoption,” where healthcare sees AI more broadly deployed across the industry, said Chris Althoff, executive vice president, marketing,…
Continue Reading
Recent advancements in large language models (LLMs) show significant potential in medical applications but are hindered by limited specialized medical knowledge. We present Me-LLaMA, a family of open-source medical LLMs integrating extensive domain-specific knowledge…
Continue Reading
Molecular subtyping and grading of adult-type diffuse gliomas are essential for treatment decisions and patient prognosis. We introduce GlioMT, an interpretable multimodal transformer that integrates imaging and clinical data to predict the molecular subtype…
Continue Reading
Academic health system Emory Healthcare is partnering with Atropos Health, a company that translates real-world clinical data into real-world evidence, to advance medication formulary decisions and protocols. Emory is piloting a program that aims to…
Continue Reading
